Clinical Trials in Tennessee

Showing 6241-6260 of 20,239 trials

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

NCT04292223

To assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease Psychosis

ACADIA Pharmaceuticals Inc.29 participantsStarted Feb 2020

Scottsdale, Arizona, United States • Fullerton, California, United States • Miami, Florida, United States +15 more locations

COMPLETEDPhase 271 miles

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

NCT05203341

The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo in participants with MDD on improving symptoms of depression.

Major Depressive Disorder

Neurocrine Biosciences183 participantsStarted Feb 2022

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Riverside, California, United States +38 more locations

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Find Trials by Condition in Tennessee

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Electronic Patient Reporting of Symptoms During Cancer Treatment

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs

Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)

Safety and Effectiveness of the Hydrus Microstent

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function